These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 26689008)

  • 61. Neurodegeneration of brain networks in the amyotrophic lateral sclerosis-frontotemporal lobar degeneration (ALS-FTLD) continuum: evidence from MRI and MEG studies.
    Trojsi F; Sorrentino P; Sorrentino G; Tedeschi G
    CNS Spectr; 2018 Dec; 23(6):378-387. PubMed ID: 29076800
    [TBL] [Abstract][Full Text] [Related]  

  • 62. TDP-43 post-translational modifications in health and disease.
    Buratti E
    Expert Opin Ther Targets; 2018 Mar; 22(3):279-293. PubMed ID: 29431050
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Full-length TDP-43 forms toxic amyloid oligomers that are present in frontotemporal lobar dementia-TDP patients.
    Fang YS; Tsai KJ; Chang YJ; Kao P; Woods R; Kuo PH; Wu CC; Liao JY; Chou SC; Lin V; Jin LW; Yuan HS; Cheng IH; Tu PH; Chen YR
    Nat Commun; 2014 Sep; 5():4824. PubMed ID: 25215604
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inflammation Induces TDP-43 Mislocalization and Aggregation.
    Correia AS; Patel P; Dutta K; Julien JP
    PLoS One; 2015; 10(10):e0140248. PubMed ID: 26444430
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Structural Integrity of Nucleolin Is Required to Suppress TDP-43-Mediated Cytotoxicity in Yeast and Human Cell Models.
    Peggion C; Massimino ML; Pereira D; Granuzzo S; Righetto F; Bortolotto R; Agostini J; Sartori G; Bertoli A; Lopreiato R
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139294
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Novel monoclonal antibodies to normal and pathologically altered human TDP-43 proteins.
    Kwong LK; Irwin DJ; Walker AK; Xu Y; Riddle DM; Trojanowski JQ; Lee VM
    Acta Neuropathol Commun; 2014 Mar; 2():33. PubMed ID: 24690345
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Muscle sympathetic nerve activity in frontotemporal lobar degeneration is similar to amyotrophic lateral sclerosis.
    Shindo K; Miwa M; Kobayashi F; Nagasaka T; Takiyama Y
    Clin Auton Res; 2016 Feb; 26(1):1-5. PubMed ID: 26607591
    [TBL] [Abstract][Full Text] [Related]  

  • 68. TDP-43-The key to understanding amyotrophic lateral sclerosis.
    Xu Z; Yang C
    Rare Dis; 2014; 2(1):e944443. PubMed ID: 26942097
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Functional implication of ubiquitinating and deubiquitinating mechanisms in TDP-43 proteinopathies.
    Tran NN; Lee BH
    Front Cell Dev Biol; 2022; 10():931968. PubMed ID: 36158183
    [TBL] [Abstract][Full Text] [Related]  

  • 70. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes.
    Kawahara Y; Mieda-Sato A
    Proc Natl Acad Sci U S A; 2012 Feb; 109(9):3347-52. PubMed ID: 22323604
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Autophagy activation ameliorates neuronal pathogenesis of FTLD-U mice: a new light for treatment of TARDBP/TDP-43 proteinopathies.
    Wang IF; Tsai KJ; Shen CK
    Autophagy; 2013 Feb; 9(2):239-40. PubMed ID: 23108236
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Cytoplasmic mislocalization of TDP-43 is toxic to neurons and enhanced by a mutation associated with familial amyotrophic lateral sclerosis.
    Barmada SJ; Skibinski G; Korb E; Rao EJ; Wu JY; Finkbeiner S
    J Neurosci; 2010 Jan; 30(2):639-49. PubMed ID: 20071528
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Partial Failure of Proteostasis Systems Counteracting TDP-43 Aggregates in Neurodegenerative Diseases.
    Cascella R; Fani G; Bigi A; Chiti F; Cecchi C
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357627
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Proteomic analyses reveal that loss of TDP-43 affects RNA processing and intracellular transport.
    Štalekar M; Yin X; Rebolj K; Darovic S; Troakes C; Mayr M; Shaw CE; Rogelj B
    Neuroscience; 2015 May; 293():157-70. PubMed ID: 25743254
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Autophagy receptor defects and ALS-FTLD.
    Majcher V; Goode A; James V; Layfield R
    Mol Cell Neurosci; 2015 May; 66(Pt A):43-52. PubMed ID: 25683489
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Identification of TCERG1 as a new genetic modulator of TDP-43 production in Drosophila.
    Pons M; Prieto S; Miguel L; Frebourg T; Campion D; Suñé C; Lecourtois M
    Acta Neuropathol Commun; 2018 Dec; 6(1):138. PubMed ID: 30541625
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Targeting TDP-43 in neurodegenerative diseases.
    Budini M; Baralle FE; Buratti E
    Expert Opin Ther Targets; 2014 Jun; 18(6):617-32. PubMed ID: 24649927
    [TBL] [Abstract][Full Text] [Related]  

  • 78. TDP-43 autoregulation: implications for disease.
    Budini M; Buratti E
    J Mol Neurosci; 2011 Nov; 45(3):473-9. PubMed ID: 21681666
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transcriptomopathies of pre- and post-symptomatic frontotemporal dementia-like mice with TDP-43 depletion in forebrain neurons.
    Wu LS; Cheng WC; Chen CY; Wu MC; Wang YC; Tseng YH; Chuang TJ; Shen CJ
    Acta Neuropathol Commun; 2019 Mar; 7(1):50. PubMed ID: 30922385
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An Amyloid-Like Pathological Conformation of TDP-43 Is Stabilized by Hypercooperative Hydrogen Bonds.
    Mompeán M; Baralle M; Buratti E; Laurents DV
    Front Mol Neurosci; 2016; 9():125. PubMed ID: 27909398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.